Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 39Carcinoma, Intraductal, Noninfiltrating 6Breast Carcinoma In Situ 5Inflammatory Breast Neoplasms 4Central Nervous System Neoplasms 3Liver Neoplasms 2Gliosarcoma 2Glioma 2Glioblastoma 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Brain Neoplasms 2Astrocytoma 2Uveal Melanoma 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Sarcoma 1Recurrence 1Pheochromocytoma 1Ovarian Neoplasms 1Osteosarcoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1

Interventions

vandetanib 2Lenalidomide 2Bortezomib 2marizomib 1enzastaurin 1carotuximab 1Tamoxifen 1Steroids 1Multiparametric Magnetic Resonance Imaging 1Irinotecan 1Dexamethasone 1Carboplatin 1Calcium Dobesilate 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Disease Progression × Tamoxifen × Clear all
NCT00108069 2015-11-05

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
43 enrolled 11 charts
CNS

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡